pith. machine review for the scientific record. sign in

arxiv: 2605.04372 · v1 · submitted 2026-05-06 · 📊 stat.ME · q-bio.QM· stat.AP

Recognition: 3 theorem links

· Lean Theorem

A Zero-Inflated Beta Mixture Model for Marginal Mediation Analysis with Compositional Microbiome Mediators

Seungjun Ahn , Quran Wu , Alicia Yang , Zhigang Li
Authors on Pith no claims yet

Pith reviewed 2026-05-08 17:59 UTC · model grok-4.3

classification 📊 stat.ME q-bio.QMstat.AP
keywords zero-inflated beta mixturemediation analysiscompositional microbiomecausal mediationpotential outcomesEM algorithmmicrobiome mediatorssparsity
0
0 comments X

The pith

A zero-inflated beta mixture model estimates marginal causal mediation effects more accurately for sparse and heterogeneous microbiome data.

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The paper develops a new statistical model to study how microbiome composition mediates the relationship between an exposure and a health outcome. Microbiome relative abundances are hard to analyze because they contain many zeros, are constrained to sum to one, and show latent subgroups with different patterns. The zero-inflated beta mixture approach adds a component that explicitly handles the excess zeros and uses a mixture of beta distributions for the positive values to capture heterogeneity. Within the potential-outcomes framework this yields estimates of the mediated causal effects, fitted by an expectation-maximization algorithm. Simulations under realistic microbiome conditions show lower bias and better coverage than existing methods, with an application to real data confirming practical use.

Core claim

The authors propose the zero-inflated beta mixture (ZIBM) model for marginal mediation analysis with compositional microbiome mediators. The model combines a zero-inflation probability with a beta mixture distribution on the non-zero relative abundances to accommodate sparsity and latent heterogeneity. Under the potential-outcomes framework it identifies and estimates marginal microbiome-mediated causal effects, with parameters obtained via an expectation-maximization algorithm. Simulation studies demonstrate more accurate estimation and reliable inference than prior approaches when data exhibit the sparsity, compositionality, and heterogeneity typical of microbiome studies; a real-data case

What carries the argument

The zero-inflated beta mixture (ZIBM) distribution, which places a point mass at zero and models positive relative abundances as a finite mixture of beta distributions, embedded in the potential-outcomes mediation framework to compute marginal indirect effects.

If this is right

  • Yields estimates of marginal microbiome-mediated causal effects that remain consistent under the zero-inflation and mixture structure.
  • Produces more accurate point estimates and better-calibrated inference than standard mediation methods when applied to typical microbiome data.
  • Extends the potential-outcomes mediation framework to data that are both compositional and zero-inflated.
  • Supports practical analysis of microbiome mediation in disease studies, as shown by the real-data illustration.

Where Pith is reading between the lines

These are editorial extensions of the paper, not claims the author makes directly.

  • The same modeling strategy could be adapted to other high-dimensional compositional mediators such as metabolomic or dietary intake profiles.
  • Incorporating variable selection or dimension reduction inside the beta mixture component might scale the method to thousands of taxa.
  • Comparing ZIBM performance across different sequencing depths or normalization choices would test robustness beyond the current simulations.

Load-bearing premise

The zero-inflated beta mixture adequately represents the sparsity, compositional constraints, and latent heterogeneity in microbiome relative abundances, and standard potential-outcomes assumptions hold without unmeasured confounding.

What would settle it

A simulation or real microbiome dataset whose relative-abundance distribution is generated from a different family (for example, a Dirichlet or zero-inflated gamma mixture) in which the ZIBM estimates of mediated effects show substantially higher bias or poorer coverage than a correctly specified alternative model.

Figures

Figures reproduced from arXiv: 2605.04372 by Alicia Yang, Quran Wu, Seungjun Ahn, Zhigang Li.

Figure 1
Figure 1. Figure 1: Causal mediation diagram for the ZIBM framework, showing the direct effect of view at source ↗
Figure 2
Figure 2. Figure 2: Heatmap of mediation strength based on NIE view at source ↗
read the original abstract

The role of the microbiome in disease pathogenesis is an emerging field with strong evidence suggesting that dysbiosis is associated with precancerous and cancerous states. Microbiome data present substantial challenges for causal mediation analysis due to sparsity, compositional constraints, and latent heterogeneity. To address these issues, we propose a zero-inflated beta mixture (ZIBM) method for mediation analysis with compositional microbiome mediators. The proposed method accommodates excess zeros through a zero-inflation component and captures heterogeneity in non-zero relative abundances using a beta mixture distribution. Within the potential-outcomes framework, the ZIBM provides estimates of marginal microbiome-mediated causal effects, and model parameters are estimated using an expectation-maximization algorithm. Simulation studies demonstrate that the ZIBM yields more accurate estimation and reliable inference under conditions commonly observed in microbiome data, compared with existing approaches. An application to a real microbiome study further illustrates its practical utility. These results indicate that the proposed method provides a more flexible and robust statistical framework for mediation analysis involving compositional microbiome data.

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, simulated authors' rebuttal, and a circularity audit. Tearing a paper down is the easy half of reading it; the pith above is the substance, this is the friction.

Referee Report

2 major / 2 minor

Summary. The manuscript proposes a zero-inflated beta mixture (ZIBM) model for marginal mediation analysis with compositional microbiome mediators. The approach uses a zero-inflation component to handle sparsity and a beta mixture to capture heterogeneity in non-zero relative abundances. Within the potential-outcomes framework, it derives estimates of natural direct and indirect effects, with parameters obtained via an EM algorithm. Simulation studies are claimed to show more accurate estimation and reliable inference than existing methods under microbiome-like conditions, and the method is illustrated on a real dataset.

Significance. If the central claims hold, the work would supply a flexible statistical framework for causal mediation analysis in microbiome research, where sparsity, compositionality, and latent heterogeneity are pervasive. The integration of zero-inflated beta mixtures with the potential-outcomes framework for marginal effects represents a targeted advance over standard mediation tools that do not accommodate these data features.

major comments (2)
  1. [§2] §2 (Model specification): The ZIBM is defined via independent zero-inflated beta distributions for each taxon, each with its own zero-inflation probability, mixture weights, and beta parameters, without any joint renormalization, Dirichlet-style dependence, or global sum-to-1 constraint. This modeling choice creates a mismatch with the compositional nature of microbiome relative abundances; under the potential-outcomes framework the resulting mediator distribution is not guaranteed to be consistent with the true data-generating process, which can bias the estimated natural direct and indirect effects even when marginal moments appear reasonable.
  2. [§4] §4 (Simulation studies): The data-generating processes used in the simulations are not described with sufficient specificity (e.g., whether taxa are drawn independently from the ZIBM or jointly from a compositional generator such as a zero-inflated Dirichlet). Without explicit recovery experiments under a joint compositional mechanism, the claim that the ZIBM yields superior performance “under conditions commonly observed in microbiome data” remains weakly supported and does not directly address the central validity concern.
minor comments (2)
  1. [Abstract] Abstract: The abstract states that simulations demonstrate superior performance but provides no outline of the simulation design, baselines, or metrics; a single sentence summarizing these elements would improve reader orientation without lengthening the abstract.
  2. [§3] Notation: The manuscript uses “marginal mediation effects” without an explicit contrast to conditional effects or a brief statement of the identifying assumptions (no unmeasured confounding, consistency, positivity) in the main text; adding a short paragraph in §3 would clarify the scope.

Simulated Author's Rebuttal

2 responses · 0 unresolved

We thank the referee for their constructive comments on our manuscript. We address the major comments point by point below, providing clarifications and indicating where revisions will be made to strengthen the paper.

read point-by-point responses

  1. Referee: [§2] §2 (Model specification): The ZIBM is defined via independent zero-inflated beta distributions for each taxon, each with its own zero-inflation probability, mixture weights, and beta parameters, without any joint renormalization, Dirichlet-style dependence, or global sum-to-1 constraint. This modeling choice creates a mismatch with the compositional nature of microbiome relative abundances; under the potential-outcomes framework the resulting mediator distribution is not guaranteed to be consistent with the true data-generating process, which can bias the estimated natural direct and indirect effects even when marginal moments appear reasonable.

    Authors: We appreciate the referee highlighting this important aspect of compositional data. Our ZIBM model is intentionally specified marginally for each taxon to enable scalable estimation of marginal mediation effects in high-dimensional settings typical of microbiome data (often hundreds of taxa). Enforcing a joint constraint such as a Dirichlet distribution would require modeling the full multivariate distribution, which is computationally prohibitive and may not be necessary for marginal causal effects. In the potential outcomes framework, the natural direct and indirect effects are defined marginally, and our approach estimates these by integrating over the marginal mediator distributions. While we acknowledge that this does not explicitly enforce the sum-to-1 constraint, empirical evidence from simulations and the real data application shows that the estimated effects are robust. To address the concern, we will revise the manuscript to include a more detailed discussion of this modeling choice and its implications for compositionality in §2. revision: partial

  2. Referee: [§4] §4 (Simulation studies): The data-generating processes used in the simulations are not described with sufficient specificity (e.g., whether taxa are drawn independently from the ZIBM or jointly from a compositional generator such as a zero-inflated Dirichlet). Without explicit recovery experiments under a joint compositional mechanism, the claim that the ZIBM yields superior performance “under conditions commonly observed in microbiome data” remains weakly supported and does not directly address the central validity concern.

    Authors: We agree that the simulation section would benefit from greater specificity. In the current manuscript, the data-generating processes are based on independent draws from zero-inflated beta distributions with parameters chosen to reflect typical microbiome characteristics such as high sparsity and heterogeneity, as observed in real datasets. However, to directly address the referee's concern about joint compositional mechanisms, we will revise the simulations to include an additional scenario where data are generated from a zero-inflated Dirichlet distribution (or similar compositional model) and evaluate the performance of ZIBM under this misspecification. This will provide stronger evidence for the method's robustness. We will also expand the description of the DGP in the revised manuscript. revision: yes

Circularity Check

0 steps flagged

No circularity: model defined independently, effects derived from potential outcomes framework

full rationale

The ZIBM is specified directly as a per-taxon zero-inflated beta mixture to capture sparsity and heterogeneity, with parameters obtained via EM on observed data. Marginal mediation effects follow from the standard potential-outcomes framework applied to the fitted conditional distributions. No equation reduces a claimed prediction to a fitted input by construction, no uniqueness theorem is imported via self-citation, and no ansatz is smuggled in. Simulations evaluate recovery under the model's own generative assumptions rather than tautologically confirming inputs. The derivation chain therefore remains self-contained.

Axiom & Free-Parameter Ledger

3 free parameters · 2 axioms · 0 invented entities

The claim rests on the ZIBM distributional assumption for mediators and standard causal inference assumptions; multiple parameters (mixture components, zero-inflation rates, beta shapes) are estimated from data via EM.

free parameters (3)
  • Beta mixture parameters
    Shape and rate parameters of beta distributions modeling non-zero relative abundances, fitted to data.
  • Zero-inflation probability
    Parameter governing the probability of excess zeros, estimated separately.
  • Mixture weights
    Weights for latent components capturing heterogeneity, fitted via EM.
axioms (2)
  • domain assumption Potential outcomes framework assumptions including no unmeasured confounding and consistency
    Invoked to define marginal microbiome-mediated causal effects.
  • ad hoc to paper Microbiome relative abundances follow a zero-inflated beta mixture distribution
    Core modeling choice to handle sparsity and heterogeneity.

pith-pipeline@v0.9.0 · 5487 in / 1322 out tokens · 129923 ms · 2026-05-08T17:59:14.483176+00:00 · methodology

discussion (0)

Sign in with ORCID, Apple, or X to comment. Anyone can read and Pith papers without signing in.

Lean theorems connected to this paper

Citations machine-checked in the Pith Canon. Every link opens the source theorem in the public Lean library.

What do these tags mean?
matches
The paper's claim is directly supported by a theorem in the formal canon.
supports
The theorem supports part of the paper's argument, but the paper may add assumptions or extra steps.
extends
The paper goes beyond the formal theorem; the theorem is a base layer rather than the whole result.
uses
The paper appears to rely on the theorem as machinery.
contradicts
The paper's claim conflicts with a theorem or certificate in the canon.
unclear
Pith found a possible connection, but the passage is too broad, indirect, or ambiguous to say the theorem truly supports the claim.

Reference graph

Works this paper leans on

34 extracted references

  1. [1]

    C., Gharaibeh, R

    Arthur, J. C., Gharaibeh, R. Z., Uronis, J. M., Perez-Chanona, E., Sha, W., Tomkovich, S., M¨ uhlbauer, M., Fodor, A. A., and Jobin, C. (2013). Vsl# 3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer.Scientific reports, 3:2868

    2013

  2. [2]

    Bautista, J., Lamas-Maceiras, M., Hidalgo-Tinoco, C., Guerra-Guerrero, A., Betancourt-Velarde, A., and L´ opez-Cort´ es, A. (2026). Gut microbiome-driven colorectal cancer via immune, metabolic, neural, and endocrine axes reprogramming.NPJ Biofilms Microbiomes, 12(1):21

    2026

  3. [3]

    and Hochberg, Y

    Benjamini, Y. and Hochberg, Y. (1995). Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing.Journal of the Royal Statistical Society. Series B, 57(1):289–300

    1995

  4. [4]

    Dan, W., Xiong, C., Zhou, G., Chen, J., and Pan, F. (2025). Gut microbiota as a mediator of can- cer development and management: From colitis to colitis-associated dysplasia and carcinoma. Biochim Biophys Acta Rev Cancer, 1880(4):189381

    2025

  5. [5]

    Dempster, A., Laird, N., and Rubin, D. (1986). Maximum Likelihood from Incomplete Data via the EM Algorithm.Journal of the Royal Statistical Society. Series B, 39(1):1–38. 16

    1986

  6. [6]

    and Tibshirani, R

    Efron, B. and Tibshirani, R. (1986). Bootstrap methods for standard errors, confidence intervals, and other measures of statistical accuracy.Statistical Science, 1(1):54–75. Gagni` ere, J., Raisch, J., Veziant, J., et al. (2016). Gut microbiota imbalance and colorectal cancer. World J Gastroenterol, 22(2):501–518

    1986

  7. [7]

    Gionchetti, P., Rizzello, F., Venturi, A., Brigidi, P., Matteuzzi, D., Bazzocchi, G., Poggioli, G., Miglioli, M., and Campieri, M. (2000). Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial.Gastroenterology, 119(2):305–309

    2000

  8. [8]

    Imai, K., Keele, L., and Tingley, D. (2010). A general approach to causal mediation analysis. Psychological Methods, 15:309–334

    2010

  9. [9]

    K., Zhao, C., et al

    Jin, C., Lagoudas, G. K., Zhao, C., et al. (2019). Commensal microbiota promote lung cancer development viaγδt cells.Cell, 176:998–1013.e16. Karpi´ nski, T., O˙ zarowski, M., and Stasiewicz, M. (2022). Carcinogenic microbiota and its role in colorectal cancer development.Semin Cancer Biol, 86(Pt 3):420–430

    2019

  10. [10]

    Kwak, S., Wang, C., Usyk, M., et al. (2024). Oral microbiome and subsequent risk of head and neck squamous cell cancer.JAMA Oncol, 10(11):1537–1547

    2024

  11. [11]

    Lagkouvardos, I., Lesker, T., Hitch, T., et al. (2019). Sequence and cultivation study of muribac- ulaceae reveals novel species, host preference, and functional potential of this yet undescribed family.Microbiome, 7(1):28

    2019

  12. [12]

    W., Sørensen, R., and Galatius, S

    Lange, T., Hansen, K. W., Sørensen, R., and Galatius, S. (2017). Applied mediation analyses: A review and tutorial.Epidemiology and Health, 39:e2017035

    2017

  13. [13]

    Li, H. (2018). Statistical and computational methods in microbiome and metagenomics. In Handbook of Statistical Genomics. Wiley

    2018

  14. [14]

    Ma, M., Zheng, Z., Li, J., He, Y., Kang, W., and Ye, X. (2024). Association between the gut mi- crobiota, inflammatory factors, and colorectal cancer: evidence from mendelian randomization analysis.Front Microbiol, 15:1309111

    2024

  15. [15]

    P., Fairchild, A

    MacKinnon, D. P., Fairchild, A. J., and Fritz, M. S. (2007). Mediation analysis.Annual Review of Psychology, 58:593–614

    2007

  16. [16]

    Madsen, K., Cornish, A., Soper, P., McKaigney, C., Jijon, H., Yachimec, C., Doyle, J., Jewell, L., and De Simone, C. (2001). Probiotic bacteria enhance murine and human intestinal epithelial barrier function.Gastroenterology, 121(3):580–591

    2001

  17. [17]

    Mousavi, S., Delgado-Saborit, J., Adivi, A., Pauwels, S., and Godderis, L. (2022). Air pollution and endocrine disruptors induce human microbiome imbalances: A systematic review of recent evidence and possible biological mechanisms.Sci Total Environ, 816:151654. 17

    2022

  18. [18]

    Oakes, D. (1999). Direct calculation of the information matrix via the em algorithm.Journal of the Royal Statistical Society Series B: Statistical Methodology, 61(2):479–482

    1999

  19. [19]

    O., Pizarro, T

    Pagnini, C., Saeed, R., Bamias, G., Arseneau, K. O., Pizarro, T. T., and Cominelli, F. (2010). Probiotics promote gut health through stimulation of epithelial innate immunity.Proceedings of the national academy of sciences, 107(1):454–459

    2010

  20. [20]

    Shah, D., Phan, F., Yu, Z., Choi, J., and Toh, J. (2025). Is the microbiome the answer to inflammatory bowel disease: systematic review.Langenbecks Arch Surg, 411(1):2

    2025

  21. [21]

    Soheilipour, M., Noursina, A., Nekookhoo, M., et al. (2025). The pathobiont role of akkermansia muciniphila in colorectal cancer: a systematic review.BMC Gastroenterol, 25(1):702

    2025

  22. [22]

    Sohn, M. B. and Li, H. (2019). Compositional mediation analysis for microbiome studies.The Annals of Applied Statistics, 13(1):661–681

    2019

  23. [23]

    K., Ahuja, V., Singal, D., Goswami, P., and Tandon, R

    Sood, A., Midha, V., Makharia, G. K., Ahuja, V., Singal, D., Goswami, P., and Tandon, R. K. (2009). The probiotic preparation, vsl# 3 induces remission in patients with mild-to-moderately active ulcerative colitis.Clinical Gastroenterology and Hepatology, 7(11):1202–1209

    2009

  24. [24]

    Tang, B., Cheng, W., Gu, A., Miao, Y., Yu, G., and Chen, J. (2026). Exploring the gut ecosystem: Mechanism studies from the gut microbiota to inflammatory cytokines to inflammatory bowel disease.Immunology, 178(2):269–279

    2026

  25. [25]

    R., et al

    Tanoue, T., Morita, S., Plichta, D. R., et al. (2019). A defined commensal consortium elicits cd8 t cells and anti-cancer immunity.Nature, 565:600–605

    2019

  26. [26]

    Terhorst, H. J. (1986). On stieltjes integration in euclidean-space.Journal of Mathematical Analysis and Applications, 114(1):57–74

    1986

  27. [27]

    VanderWeele, T. J. (2009). Marginal structural models for the estimation of direct and indirect effects.Epidemiology, 20:18–26

    2009

  28. [28]

    VanderWeele, T. J. (2015).Explanation in Causal Inference: Methods for Mediation and Inter- action. Oxford University Press

    2015

  29. [29]

    VanderWeele, T. J. (2016). Mediation analysis: A practitioner’s guide.Annual Review of Public Health, 37:17–32

    2016

  30. [30]

    J., and Li, H

    Wang, C., Hu, J., Blaser, M. J., and Li, H. (2020). Estimating and testing the microbial causal mediation effect with high-dimensional and compositional microbiome data.Bioinformatics, 36(2):347–355

    2020

  31. [31]

    Wang, X., Sun, G., Feng, T., et al. (2019). Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit alzheimer’s disease progression.Cell Research, 29:787–803. 18

    2019

  32. [32]

    Wu, Q., O’Malley, J., Datta, S., Gharaibeh, R., Jobin, C., Karagas, M., et al. (2022). Marzic: A marginal mediation model for zero-inflated compositional mediators with applications to microbiome data.Genes (Basel), 13:1049

    2022

  33. [33]

    Zhang, H., Chen, J., Li, Z., and Liu, L. (2019). Testing for mediation effect with application to human microbiome data.Statistical Biosciences

    2019

  34. [34]

    Zhang, X., Yu, D., Wu, D., et al. (2023). Tissue-resident lachnospiraceae family bacteria protect against colorectal carcinogenesis by promoting tumor immune surveillance.Cell Host Microbe, 31(3):418–432.e8. 19

    2023